Jefferies analyst Akash Tewari increased the price target for Pfizer (NYSE:PFE) shares from $33.00 to $34.00, while reiterating a Buy rating on the stock. Currently trading at $25.72, near its 52-week ...

A former NYU housing manager is suing the university for religious-based discrimination, claiming he was wrongfully ...

NIH grant recipients receive additional funding to cover "indirect costs," such as building maintenance and administrative ...

On Friday, the U.S. Judicial Panel on Multidistrict Litigation ordered nearly 70 lawsuits be coordinated beefore U.S.

At-home rapid tests for COVID-19 and influenza are becoming available, allowing simultaneous diagnosis, which aids timely and effective treatment and improves patient outcomes.

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

The tech billionaires who attended the inauguration of President Donald J. Trump are not the oligarchs seen in Russia or ...

Dr. Paulo H. Verardi, a virologist and head of the Department of Pathobiology and Veterinary Science at the University of ...

Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...

The doctor beamed onto a health clinic video screen in October to convince the regional health board to ban public clinics in ...

There are some new tools to help this respiratory virus season: over-the-counter tests that can identify whether an illness ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...